drugset / Trial / NCT01601717
RTI-336 as a Treatment for Methamphetamine Dependence
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of this study is to evaluate the safety and efficacy of RTI-336 as a treatment for methamphetamine (METH) dependence in non-treatment-seeking METH-dependent volunteers.
Timeline
- Start
- 2010-01
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | RTI-336 | Small molecule | 0 mg | Oral |
| Comparator | RTI-336 | Small molecule | 1 mg | Oral |
| Comparator | RTI-336 | Small molecule | 12 mg | Oral |
| Comparator | RTI-336 | Small molecule | 20 mg | Oral |